Your browser doesn't support javascript.
loading
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera.
Hutchinson, Geoffrey B; Abiona, Olubukola M; Ziwawo, Cynthia T; Werner, Anne P; Ellis, Daniel; Tsybovsky, Yaroslav; Leist, Sarah R; Palandjian, Charis; West, Ande; Fritch, Ethan J; Wang, Nianshuang; Wrapp, Daniel; Boyoglu-Barnum, Seyhan; Ueda, George; Baker, David; Kanekiyo, Masaru; McLellan, Jason S; Baric, Ralph S; King, Neil P; Graham, Barney S; Corbett-Helaire, Kizzmekia S.
  • Hutchinson GB; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Abiona OM; Institute for Protein Design, University of Washington School of Medicine, Seattle, WA, USA.
  • Ziwawo CT; Department of Immunology, University of Washington School of Medicine, Seattle, WA, USA.
  • Werner AP; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Ellis D; Case Western Reserve University, Cleveland, OH, USA.
  • Tsybovsky Y; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Leist SR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Palandjian C; Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • West A; Institute for Protein Design, University of Washington School of Medicine, Seattle, WA, USA.
  • Fritch EJ; Department of Biochemistry, University of Washington School of Medicine, Seattle, WA, USA.
  • Wang N; Vaccine Research Center Electron Microscopy Unit, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Wrapp D; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Boyoglu-Barnum S; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Ueda G; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Baker D; Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Kanekiyo M; College of Natural Sciences, University of Texas at Austin, Austin, USA.
  • McLellan JS; College of Natural Sciences, University of Texas at Austin, Austin, USA.
  • Baric RS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • King NP; Institute for Protein Design, University of Washington School of Medicine, Seattle, WA, USA.
  • Graham BS; Department of Biochemistry, University of Washington School of Medicine, Seattle, WA, USA.
  • Corbett-Helaire KS; Institute for Protein Design, University of Washington School of Medicine, Seattle, WA, USA.
Nat Commun ; 14(1): 6195, 2023 10 04.
Article en En | MEDLINE | ID: mdl-37794071

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / Coronavirus del Síndrome Respiratorio de Oriente Medio Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / Coronavirus del Síndrome Respiratorio de Oriente Medio Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article